Head Office: E–219, Greater Kailash, Part 1, New Delhi–110 048, India. e–mail: emedinews@gmail.com, Website: www.ijcpgroup.com
eMedinewS is now available online on www.emedinews.in or www.emedinews.org
  From the Desk of Editor–in–Chief
Dr KK Aggarwal

Padma Shri and Dr B C Roy National Awardee
Dr KK Aggarwal
President, Heart Care Foundation of India; Sr Consultant Physician, Cardiologist & Dean Medical Education Moolchand Medcity; Chairman Ethical Committee Delhi Medical Council; Chairman (Delhi Chapter) International Medical Sciences Academy; National Vice President Elect Elect, Indian Medical Association; Hony Director IMA AKN Sinha Institute (08–09); Hony Finance Secretary National IMA (07–08); Chairman IMA Academy of Medical Specialties (06–07); President Delhi Medical Association (05–06), President IMA New Delhi Branch (94–95, 02–04); Editor in Chief IJCP Group & Hony. Visiting Professor (Clinical Research) DIPSAR

For updates follow at www.twitter.com/DrKKAggarwal     www.facebook.com/Dr KKAggarwal

    Health Videos …
Nobility of medical profession Video 1 to 9 Health and Religion Video 1 to 7
DD Take Care Holistically Video 1 to 9 Chat with Dr KK On life Style Disorders
Health Update Video 1 to 15 Science and Spirituality
Obesity to Towards all Pathy Consensus ALLOVEDA: A Dialogue with Dr KK Aggarwal
  Editorial …

1st December 2012, Saturday

Today is World AIDS Day

World AIDS Day 2012 theme: “Getting to Zero” Zero New HIV Infections, Zero Discrimination and Zero AIDS Related Deaths.

NIH Statement on World AIDS Day 2012

The International AIDS Conference in Washington, D.C., this past summer energized HIV/AIDS researchers and focused on the potential benefits of broadly implementing scientifically proven HIV prevention and treatment tools. On World AIDS Day, the National Institutes of Health joins with our global partners to maintain this momentum toward a world without AIDS. As the world’s leading funder of HIV/AIDS research, NIH is vigorously pursuing promising research in therapeutics, prevention (including efforts to develop a vaccine), and work toward a cure, while also studying how best to deliver these interventions to people who need them.

NIH-funded researchers have contributed to the development of the more than 30 antiretroviral drugs and drug combinations currently available, which have saved millions of lives. Additionally, NIH partners with pharmaceutical companies to identify optimal treatment regimens. We continue to pursue the development of new antiretroviral drugs that are longer acting, simpler to use, and less toxic than currently available therapies.

NIH also supports studies on how to improve HIV treatment outcomes and how to manage and reduce the incidence of diseases and complications associated with long-term HIV disease and antiretroviral therapy.

But with 2.5 million new HIV infections in 2011 alone, we must not only treat people living with HIV but also continue efforts to prevent new infections. In collaboration with our partners in the U.S. government, other governments, nongovernmental organizations, and scientists around the world, NIH is leading the effort to further develop a robust combination of HIV prevention strategies that could bring about the end of AIDS.

To that end, we have learned that the treatment of HIV-infected individuals with antiretroviral drugs can — by lowering the level of virus in the treated individual — also prevent HIV infection of sexual partners, as the NIH-supported HPTN 052 clinical trial demonstrated last year. Yet less than a third of HIV-infected people in the United States are being treated successfully for their infection such that the virus is fully suppressed, and similarly low percentages have been observed in other countries. To address this problem, the NIH-funded HPTN 065 study in the United States is assessing the feasibility of widespread HIV testing, immediately linking HIV-infected individuals to care, and providing incentives to suppress the virus through treatment. Beginning in 2013, the NIH co-funded HPTN 071 study will examine whether the implementation of a comprehensive set of HIV prevention strategies including universal, voluntary HIV testing and linkage to care can reduce the annual number of new HIV infections among 1.2 million South Africans and Zambians.

Other landmark studies funded by NIH and its partners have tested and proven the effectiveness of powerful HIV prevention strategies. These include using antiretroviral drugs to prevent mother-to-child transmission of the virus; performing voluntary adult medical male circumcision; and taking a daily oral dose of one or two antiretroviral drugs as pre-exposure prophylaxis. We have long known that correct and consistent condom use can prevent sexual transmission of the virus, but the success of many proven HIV prevention modalities now rests to a great extent on how well we can promote adherence to them. Consequently, NIH supports a substantial portfolio of behavioral research to achieve these goals. In addition, NIH is partnering with the President's Emergency Plan for AIDS Relief, or PEPFAR, on implementation research to determine how best to put scientifically validated HIV prevention and treatment tools into use on an increasingly wider scale.

One key HIV prevention research challenge is to build on the progress made in developing and testing microbicides — that is, substances that can be applied topically to prevent sexually transmitted HIV infection. Such tools would be particularly helpful to women by giving them control over HIV prevention. This year NIH launched the multinational ASPIRE clinical trial to test whether the drug dapivirine can safely prevent HIV infection when continuously released from a silicone cervical ring replaced once a month. The ring was designed to reflect women's potential preference for a device that is more convenient and easier to incorporate into their lives than a gel that must be applied daily or before and after sex.

A major remaining HIV prevention research challenge is the discovery and development of a safe and effective vaccine. Widely implementing combinations of existing scientifically proven HIV prevention strategies and introducing a highly effective HIV vaccine would cause the annual number of new HIV infections to plummet, according to mathematical models. This year, NIH-supported scientists studying specimens and data from the landmark RV144 clinical trial discovered that participants who produced relatively high levels of a specific antibody after vaccination were less likely to get infected with the virus than those who did not. In addition, NIH scientists and grantees have discovered powerful antibodies that can neutralize a broad range of HIV strains and are working to design vaccines that can elicit such antibodies in HIV-uninfected people.

Along with a vaccine, another key remaining HIV research challenge is to find a cure for the 34 million people infected with the virus. NIH-supported scientists are pursuing two strategies: eliminating HIV from the body, and suppressing HIV to the point that medication is no longer needed.

(Dr Anthony S. Fauci, Dr Jack Whitescarver and Dr Francis S. Collins)

For More editorials…

Dr KK Aggarwal
Group Editor in Chief

    Constipation Update

Constipation is defined as any two of the following features: straining, lumpy hard stools, sensation of incomplete evacuation, use of digital maneuvers, sensation of anorectal obstruction or blockage with 25 percent of bowel movements, and decrease in stool frequency (less than three bowel movements per week).

For Comments and archives…

Dr K K Aggarwal
  eMedinewS Audio PostCard

Stay Tuned with Padma Shri and Dr BC Roy National Awardee Dr KK Aggarwal

Give thiazides only to obese hypertensives

Audio PostCard
    Photo Feature (from the HCFI Photo Gallery)

19th MTNL Perfect Health Mela 2012

Large number of nursing students actively participated in the recently concluded 19th MTNL Perfect Health Mela

Dr K K Aggarwal
    National News

Dear Colleague, Let’s celebrate New Year by learning CPR-10 and saving the life of a person

Watch English or Hindi Video @http://emedinews.in/videos/cpr/index.html

Dr K K Aggarwal

Kolkata ranks 7th highest in climate change in coming decades

Kolkata is a climate vulnerable city and according to a study ranked seventh in the global list of cities facing the highest climate change in the coming decades, British Deputy High Commissioner (Eastern India), Sanjay Wadhwani said today. "We know that climate change will impact business and the Kolkata economy in sectors such as buildings, power, water and energy supply," Wadhwani said, announcing the launch of a study by the Centre for Low Carbon Futures (CLCF) and Jadavpur University. Backed by the British Deputy High Commission, the study 'The Economics of a Low Carbon Kolkata as part of the 10 Climate Smart Cities' would be conducted in the Kolkata Metropolitan Area and would help identify relevant policies to attract investment. The KMA was chosen for the study because it is one of the 10 largest cities in the world and is growing at a rapid rate. Jadavpur University Professor Joyashree Roy said the programme would create a global network of cities representing different climates and states of development and reflecting varied approaches to green growth and concerns relating to climate change mitigation and adaptation. "We will identify the projects for reducing carbon emissions and green growth. We will also suggest cost effective ways for implementation of those projects," Roy said. West Bengal Pollution Control Board (WBPCB) Chairman Binay K Datta said, "We will have to streamline issues and areas before making a bigger plan for energy conservation. "One-third of the water supply in the city is wasted because of silly reasons like pipe leakage, we need to plug such loopholes," he said. "Even transport, we need more of elevated and underground metros to stop too much dependency on fuel-based transport," he said. He added that even housing projects needed to be designed in a way that lights and other electricity-based connections are wisely used. (Source: Indian Express, Nov 29, 2012)

Medical mistakes in Indian movies

Dear all, eMedinewS is starting a special series on ‘Medical mistakes in Indian movies’. We invite all our readers to share with us the following information:

  1. Scene/s where the image of the medical profession has been maligned in an unrealistic manner, or
  2. Scene/s where medical care and approach has been depicted incorrectly, or
  3. Scenes where the medical profession has been portrayed correctly.

Send us the clippings or description of the scenes. This would be a start to a special campaign to rebuild the image of the medical profession.

Certificate courses in 2D and 3D Echocardiography/Fellowship Diploma in non invasive cardiology Contact Dr KK Aggarwal, Moolchand Medcity, email: emedinews@gmail.com

    Valvular Heart Disease Update

Valvular heart disease and CKD

Valvular heart disease is common in patients undergoing maintenance dialysis. Predisposing factors include secondary hyperparathyroidism, an elevated calcium-phosphorus product, vascular calcification, hypercalcemia, uremic milieu and hyperphosphatemia.

(Experts: Dr Ganesh K Mani, Dr Yugal Mishra, Dr Deepak Khurana, Dr Rajesh Kaushish, Dr K S Rathor, Dr Sandeep Singh and Dr KK Aggarwal)

For comments and archives

    International News

(Contributed by Dr Monica and Brahm Vasudev)

New sleep drug passes early clinical test

Insomniacs had statistically significant, dose-related improvement in sleep efficiency over 4 weeks when treated with a new class of sleep aid, results of a placebo-crossover trial showed. (Source: Medpage Today)

New type of TB drug wins FDA panel support

An FDA advisory committee voted 11-7 on Wednesday in support of the safety of a tuberculous drug with a new mechanism of action, while unanimously supporting its effectiveness. The drug, bedaquiline (Sirturo) inhibits the production of energy in mycobacterial cells, and no other anti-mycobacterial agents have the same mechanism of action. Because of that, it's seen as a prospect in offsetting the bug's drug-resistant strain. (Source: Medpage Today)

Pelvic inflammatory disease risk low with IUD

Women who undergo insertion of intrauterine devices (IUDs) are at low risk for development of pelvic inflammatory disease (PID) whether or not they have been screened for chlamydia and gonorrhea before insertion of the device, according to results from a newly published study of nearly 60,000 women. The study was published in the December issue of Obstetrics & Gynecology. (Source: Medscape)

HIV therapy may lower malaria risk

For HIV-positive children at risk for malaria, the choice of antiretroviral therapy (ART) appears to affect the risk of acquiring the mosquito-borne disease, researchers reported. (Source: Medpage Today)

Ponatinib 'best of the bunch' in Ph-positive leukemia?

In a group of heavily pretreated patients with Philadelphia (Ph)-chromosome-positive leukemia resistant to currently available tyrosine kinase inhibitors (TKIs), including patients with the BCR-ABL T315I mutation, ponatinib showed significant clinical activity in a phase 1 study published in the November 29 issue of the New England Journal of Medicine. (Source: Medscape)

  Twitter of the Day

@DrKKAggarwal: Children And Adolescents With Congenital Heart Disease Should Avoid Body Piercing http://blog.kkaggarwal.com/2012/11/children-and-adolescents-with-congenital-heart-disease-should-avoid-body-piercing/ …

@DeepakChopra: Can yoga lower blood pressure? http://www.youtube.com/watch?v=sGTweKYlzhY&feature=plcp …

    Spiritual Update

(Dr KK Aggarwal, Group Editor in Chief, IJCP Group of Publications and eMedinews)

Vedic science behind continuing post- traumatic stress disorder?

PTSD is a stress, which lasts for up to 13 days, if handled properly and for months or years, if not handled after an acute stress. This can be a serious disorder. The reference to grieved mourning a death can be found in the Vedic literature. There is custom that the grieved partner is made to weep till she or he is overwhelmed with emotions. In fact, all relatives and friends participate in the exercise, depending upon their respective closeness to the deceased.

For comments and archives

    Infertility Update (Dr Kaberi Banerjee, IVF expert, New Delhi)

What is the difference between a surrogate and a gestational carrier?

A surrogate is a woman who agrees to become pregnant using your partner’s sperm and her own egg. The child will be genetically related to the surrogate and your partner, and the surrogate will give you and your partner the baby after delivery.

A gestational carrier is an option for women who have had a hysterectomy but still retain their ovaries, or for women who should not become pregnant due to medical reasons. If you use a gestational carrier, your eggs are fertilized by your partner’s sperm and the resulting embryos placed in the uterus of the carrier. You and your partner will be genetically related to the child, but the carrier will not. She will give the baby to you and your partner at birth.

    Tat Tvam Asi………and the Life Continues……

(Dr N K Bhatia, Medical Director, Mission Jan Jagriti Blood Bank)

Anti-A and B produced in the mother being natural are IgM molecules and so do not cross placenta.

    An Inspirational Story (Dr GM Singh)

Do not judge, and you will never be mistaken

Everything in life holds both a blessing and a curse. We deny this when we label the events of our lives as either good or bad. The following old Zen story illustrates this lesson most effectively.

A farmer had a horse but one day, the horse ran away and so the farmer and his son had to plow their fields themselves. Their neighbors said, "Oh, what bad luck that your horse ran away!" But the farmer replied, "Bad luck, good luck, who knows?"

The next week, the horse returned to the farm, bringing a herd of wild horses with him. "What wonderful luck!" cried the neighbors, but the farmer responded, "Good luck, bad luck, who knows?"

Then, the farmer's son was thrown as he tried to ride one of the wild horses, and he broke his leg. "Ah, such bad luck," sympathized the neighbors. Once again, the farmer responded, "Bad luck, good luck, who knows?"

A short time later, the ruler of the country recruited all young men to join his army for battle. The son, with his broken leg, was left at home. "What good luck that your son was not forced into battle!" celebrated the neighbors. And the farmer remarked, "Good luck, bad luck, who knows?"

For comments and archives

  Cardiology eMedinewS

Cost to save one athlete's life with ECG screening? Read More

Pall cast on Durata ICD lead as FDA document made public Read More

  Pediatric eMedinewS

Early cirrhosis common in children with cystic fibrosis Read More

Clues to autism emerge from brain imaging Read More

    IJCP Special

Dr Good Dr Bad

Situation: A 39–year–old male with community–acquired pneumonia came for OPD treatment.
Dr Bad: You need admission for IV ceftriaxone therapy.
Dr Good: Take levofloxacin 500 mg orally.
Lesson: A prospective, randomized, multicenter trial of 599 adults with community-acquired pneumonia who could be treated as an outpatient or in the hospital compared the efficacy of levofloxacin (500 mg IV or orally daily) to ceftriaxone (1 to 2 g IV once or twice daily) and/or cefuroxime (500 mg orally twice daily) with or without erythromycin or doxycycline. Clinical success at 5 to 7 days after treatment was superior with levofloxacin (96%) compared with either cephalosporin arm (85%). Levofloxacin eradicated 100% of the most frequently reported respiratory pathogens (Antimicrob Agents Chemother 1997;41(9):1965–72).

Make Sure

Situation: A patient with suspected heart attack with blood pressure of 40 mm Hg with warm peripheries died?
Reaction: Oh my God! Why was a diagnosis of anaphylaxis not considered?
Lesson: Make sure all patients with warm shock are managed on the lines of sepsis or anaphylaxis. Heart attack will present as cold shock.

  Quote of the Day (Dr GM Singh)

Twenty years from now you will be more disappointed by the things you didn't do than by the ones you did do. So throw off the bowlines. Sail away from the safe harbor. Catch the trade winds in your sails. Explore. Dream. Discover. Mark Twain

    Mind Teaser

Read this…………………

The key factor in accurately assessing how body image changes will be dealt with by the client is the:

A. Extent of body change present
B. Suddenness of the change
C. Obviousness of the change
D. Client’s perception of the change

Yesterday’s Mind Teaser: A client jokes about his leukemia even though he is becoming sicker and weaker. The nurse’s most therapeutic response would be:

A. “Your laugher is a cover for your fear.”
B. “He who laughs on the outside, cries on the inside.”
C. “Why are you always laughing?”
D. “Does it help you to joke about your illness?”

Answer for Yesterday’s Mind Teaser: D. “Does it help you to joke about your illness?”

Correct answers received from: Shubh Chhatwal, Prabha Sanghi, Dr Suresh Arora, Dr (Maj. Gen.) Anil Bairaria, Archna Parwani, Dr Jainendra Upadhyay,
Dr Thakor Hitendrsinh G Dr Pankaj Agarwal, Dr Chandresh Jardosh Muthumperumal Thirumalpillai, Dr KV Sarma.

Answer for 29th November Mind Teaser: (C) Allow the denial but be available to discuss death

Correct answers received from: Dr KV Sarma,, Dr Avtar Krishan , Dr Ajay Gandhi, Dr CK Gupta.

Send your answer to ijcp12@gmail.com

    Laugh a While (Dr GM Singh)

An elderly woman decided to have her portrait painted. She told the artist: “Paint me with diamond ear-rings, a diamond necklace, emerald bracelets, a ruby brooch and a gold Rolex.”

The confused artist said: “But you’re not wearing any of those things.” “I know,” she said. “But if I die before my husband, I’m sure my husband will remarry. And I want his new wife to go crazy looking for the jewelry.”

    Medicolegal Update

(Dr Sudhir Gupta, Additional Prof, Forensic Medicine & Toxicology, AIIMS)

Section 324 of IPC in medical practice

Section 324. Voluntarily causing hurt by dangerous weapons or means: "Whoever, except in the case provided for by section 334, voluntarily causes hurt by means of any instrument for shooting, stabbing or cutting, or any instrument which, used as weapon of offence, is likely to cause death, or by means of fire or any heated substance, or by means of any poison or any corrosive substance, or by means of any explosive substance or by means of any substance which it is deleterious to the human body to inhale, to swallow, or to receive into the blood, or by means of any animal, shall be punished with imprisonment of either description for a term which may extend to three years, or with fine, or with both".

It is the duty of the attending doctor to record all injuries, their dimension as much as possible, and the body parts where the injuries are located; the nature of injury whether simple or grievous, whether caused by sharp/blunt object, age or duration of injury and vital parameters like blood pressure, pulse respiration along with the mental status of the patient.

When an investing officer comes to the hospital he needs some specific answers for his legal investigation and to book a case under the law of land.

  • Are the injuries present self–inflicted or fabricated? If yes, please mention the forensic justification.
  • Are there any signs/symptoms or smell of alcohol or any drug intoxication? If yes, please opine about the mental status due the influence of intoxication. Also, preserve the sample of blood.
  • Please opine if the injured or intoxicated patient is fit to give statement? If no, please give due reasons and an approximate time interval for medical re–evaluation for his/her fitness for statement.
  • Is the condition of patient critical, severe or serious? If so, the dying declaration must be recorded by attending doctor before one or two witnesses.

For comments and archives

Our Social
Network sites
… Stay Connected

  > Dr K K Aggarwal
  > eMedinewS
  > Hcfi NGO
  > IJCP Group

  > Dr K K Aggarwal
  > eMedinewS
  > IJCP Group

  > Dr K K Aggarwal
  > eMedinewS
  > IJCP Group

        You Tube
  > Dr K K Aggarwal
  > eMedinewS

central bank
lic bank
emedinews revisiting 2011
emedinews revisiting 2011

Photos and Videos of 3rd eMedinewS – RevisitinG 2011 on 22nd January 2012

Photos of Doctor’s Day Celebration

eMedinewS Apps
    Public Forum

Public Forum (Press Release for use by the newspapers)

Smoker’s cough strong predictor of lung disease

People who develop chronic cough and phlegm (sputum production) are at significantly high risk of developing chronic obstructive artery disease (COAD), said Padma Shri & Dr. B.C. Roy National Awardee, Dr. KK Aggarwal, President, Heart Care Foundation of India.

COAD, also called as chronic obstructive pulmonary disease (COPD), is the fourth leading cause of death. It is a combination of chronic bronchitis and emphysema where the lungs get enlarged and weak. The main cause of COAD is smoking.

Quoting a study published in the American Journal of Respiratory and Critical Care Medicine, Dr. Aggarwal said that the presence of chronic cough and phlegm in smokers is not an innocent symptom but is an early marker of airflow obstruction. In the study, people who developed chronic cough and phlegm had a four fold higher risk of developing COAD. Until now it was thought that only 15% of smokers develop COAD but the current literature suggests that the lifetime risk of COAD in smokers is more than 50%. If not managed properly COAD leads to heart involvement resulting into right heart failure with increased morbidity and mortality.

Quitting smoking can reverse the process in the early stages. In late stages, quitting will stop further progression of the disease.

    Readers Response
  1. Dear Dr KK, We all know that summer holidays across the globe are longer than winter holidays of Dec and Jan and hence it becomes difficult to believe all the reasons in your press release related to holidays playing up during winters but not during summers. The sensible reason as I have understood from a medical technician with experience of 40 years in hyperbaric medicine in a recent conference at Isle of Man - is the low pressures of O2 in the atmosphere on a cloudy day than on a sunny day. Due to low pressure of O2 in atmosphere, the amount of O2 dissolved in our system is also less (an example is the gas dissolved in champagne, which makes the cork fly when bottle is opened) and on a sunny day the O2 levels are high in our blood due to high atmospheric O2 pressures and that is why we all feel good on a sunny days as more O2 is flowing and reaching end organs and hence less heart attacks. O2 is also not a free radical as being propounded by some talking damage by hyperoxemia due to which some units do not give O2 to MI patients if pulse oximeter is showing good saturations. While in sepsis patient O2 is first line to be started despite normal saturations with normal respiratory rate. So the moral is - give more O2 and especially if the weather is cloudy due to low O2 pressures in external atmosphere. Or maybe we should carry portable O2 cylinders in these 2 months, if have risks of IHD?? Regards: Vivek.
    Forthcoming Events

Pushpanjali Crosslay Hospital, is organizing PCCON-2012 (4th Annual Conference) in association with IMA East Delhi Branch and IMA West Ghaziabad Branch on 1st & 2nd Dec, 2012 at Hotel Country Inn, Sahibabad, Ghaziabad.

PC CON-2012” will be a multi-specialty conference covering a wide range of scientific sessions by eminent national and international speakers presenting the latest developments in the field of medical science.

“PC CON-2012” is the 4th Annual conference and more than 1000 delegates from all over the country are expected to attend.

Dr Gaurav Aggarwal, Organizing Secretary

Dr. N.P. Singh, Organizing Co-Chairman

Dr. Ganesh K. Mani, Organizing Chairman, Director & Sr. Consultant, Cardiovascular Surgeon

Encl: Brochure and scientific programme

Seminar on "Mind and Body in Health and Harmony in Asian Systems of Medicine"

Date: December 11-13, 2012
Venue: India International Centre, New Delhi
Themes of the Workshop: Anatomy, Philosophy, Diagnostics and imbalances, Therapeutics and treatments, Understanding Mind-Body relationships and Preventive and Promotive aspects in the traditional systems of medicine

4th eMedinews Revisiting 2012

(a day long single hall medical conference on 2012 happenings, followed by doctors of the year 2012 awards)

Sunday 20th January 2013, Maulana Azad Medical College Auditorium

Dilli Gate Delhi


Dr KK Aggarwal
Padmashri and Dr B C ROY National Awardee President

Dr Veena Aggarwal
Executive Editor IJCP Group
Organizing Chairman

Dr Pawan Gupta
Past President IMA Haryana
Organizing Secretary

4th eMedinewS Revisiting 2012

The 4th eMedinewS–revisiting 2012 conference is being held at Maulana Azad Medical College, New Delhi on Sunday January 20th 2013.

The one–day conference will revisit and discuss all the major advances in medicine in the year 2012. There will also be a live webcast of the event. An eminent faculty will speak at the conference.

There is no registration fee. All delegates will get Registration Kit, Attractive gifts, Certificates. Morning snacks and lunch will be provided.

Register at: www.emedinews.in/


4th eMedinewS Doctor of the Year Awards

Nominations invited for 4th eMedinewS Doctor of the year Award in plain paper. Nominated by 2 professional colleagues along with details of your contributions in the year 2012.

pls send his/her Biodata at: emedinews@gmail.com

    eMedinewS Special

1. IJCP’s ejournals (This may take a few minutes to open)

2. eMedinewS audio PPT (This may take a few minutes to download)

3. eMedinewS audio lectures (This may take a few minutes to open)

4. eMedinewS ebooks (This may take a few minutes to open)

Activities eBooks



  Playing Cards

  Dadi Ma ke Nuskhe

  Personal Cleanliness

  Mental Diseases

  Perfect Health Mela

  FAQs Good Eating

  Towards Well Being

  First Aid Basics

  Dil Ki Batein

  How to Use

  Pesticides Safely

    Our Contributors

Dr Veena Aggarwal, Dr Arpan Gandhi, Dr Aru Handa, Dr Ashish Verma, Dr A K Gupta, Dr Brahm Vasudev, Dr GM Singh, Dr Jitendra Ingole, Dr Kaberi Banerjee (banerjee.kaberi@gmail.com), Dr Monica Vasudev, Dr MC Gupta, Dr Neelam Mohan (drneelam@yahoo.com), Dr Navin Dang, Dr Pawan Gupta(drpawangupta2006@yahoo.com), Dr Parveen Bhatia, (bhatiaglobal@gmail.com), Dr Prabha Sanghi, Dr Prachi Garg, Rajat Bhatnagar (http://www.isfdistribution.com), Dr. Rajiv Parakh, Dr Sudhir Gupta